All Stories

  1. Gastro-retentive Nanocarriers in Drug Delivery
  2. Reactive oxygen nano-generators for cancer therapy
  3. Emerging ROS-Modulating Technologies for Augmentation of the Wound Healing Process
  4. Current trends in theranostic nanomedicines
  5. Engineering immunity via skin-directed drug delivery devices
  6. Environmental and safety aspects of bionanotechnology
  7. Factors influencing drug toxicity
  8. Food–drug interactions and their implications on oral drug bioavailability
  9. Importance of toxicity testing in drug discovery and research
  10. In silico methods for the prediction of drug toxicity
  11. List of contributors
  12. Methods and models for in vitro toxicity
  13. Principles and concepts in toxicokinetic
  14. Toxicity and toxicokinetic considerations in product development and drug research
  15. Toxicity of pharmaceutical azo dyes
  16. Toxicokinetic and toxicodynamic considerations in drug research
  17. Understanding the concept of signal toxicity and its implications on human health
  18. Recent advancements and future submissions of silica core-shell nanoparticles
  19. Biosimilars accessible in the market for the treatment of cancer
  20. 5-Fluorouracil Loaded Orally Administered WGA-decorated Poly(lacticco- glycolic Acid) Nanoparticles for Treatment of Colorectal Cancer: In Vivo Evaluation
  21. Nanomedicines accessible in the market for clinical interventions
  22. The role of nanoparticles in the treatment of gastric cancer
  23. D-Mannose-Decorated Chitosan Nanoparticles for Enhanced Targeting of 5-Fluorouracil in the Therapy of Colon Cancer
  24. Bioanalytical method development and validation for establishing bioavailability and bioequivalence
  25. Biopharmaceutical considerations in the pediatric and geriatric formulation development
  26. Chronopharmacokinetics
  27. Drug metabolic kinetics
  28. Implications for sex-related issues in clinical pharmacology and biopharmaceutics
  29. Influence of fever on pharmacokinetics of drugs
  30. Kinetics of maternal–fetal drug transfer
  31. List of contributors
  32. List of contributors
  33. Microdialysis: an emerging technique for pharmacokinetic–pharmacodynamic profiling
  34. Molecular mechanisms of circadian rhythm and its influence on the pharmacokinetics of drugs
  35. Overview of biopharmaceutics and pharmacokinetics
  36. Pharmacogenomics and drug metabolism
  37. Pharmacokinetic characterization of drugs and new product development
  38. Pharmacokinetics and biopharmaceutics: “a leader or attendant”
  39. Pharmacokinetics aspects of biotechnological products
  40. Pharmacokinetics aspects of structural modifications in drug design and therapy
  41. Pharmacokinetics modeling in drug delivery
  42. Positron emission tomography as a noninvasive tool in pharmacokinetic studies
  43. Revamping the pharmacokinetics of poorly soluble drugs using different formulations
  44. Software used in ADME computation
  45. “Organ-on-a-chip”-based physiologically relevant pharmacokinetic models
  46. 99mTc-labelled and pH-awakened microbeads entrapping surface-modified lipid nanoparticles for the augmented effect of oxaliplatin in the therapy of colorectal cancer
  47. Development of Metronidazole Loaded Chitosan Nanoparticles Using QbD Approach—A Novel and Potential Antibacterial Formulation
  48. Development and Evaluation of Cholestyramine-Amoxicillin Trihydrate-Loaded Gastro-Retentive Microspheres for Attaining Extended Therapeutic Effect Against H. Pylori Infection
  49. Expedition of Eudragit® Polymers in the Development of Novel Drug Delivery Systems
  50. Oral delivery of pH-responsive alginate microbeads incorporating folic acid-grafted solid lipid nanoparticles exhibits enhanced targeting effect against colorectal cancer: A dual-targeted approach
  51. Lipid-based Nanoplatforms in Cancer Therapy: Recent Advances and Applications
  52. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines
  53. Self-microemulsifying drug-delivery system: ongoing challenges and future ahead
  54. Cancer-targeted chemotherapy: Emerging role of the folate anchored dendrimer as drug delivery nanocarrier
  55. 3D printing as an emerging tool in pharmaceutical product development
  56. Dendrimers as novel drug-delivery system and its applications
  57. Hydrotropy, mixed hydrotropy, and mixed solvency as trending concept for solubilization of lipophilic drugs
  58. Resealed erythrocytes (RBCs) and their biomedical application
  59. Gene delivery to tackle diabetic nephropathy
  60. New advances in insulin products
  61. Endosomal escape tendency of drug delivery systems to mediate cytosolic delivery of therapeutics
  62. Gold nanoparticles: An advanced drug delivery and diagnostic tool
  63. Recombinant blood products and therapeutic enzymes: An update
  64. Recent advances in regenerative medicine
  65. Recent advancements in solubilization of hydrophobic drugs
  66. Contributors
  67. List of contributors
  68. Solid Lipid Nanoparticles: A Promising Nanomaterial in Drug Delivery
  69. Correction
  70. Irinotecan hydrochloride trihydrate loaded folic acid-tailored solid lipid nanoparticles for targeting colorectal cancer: development, characterization, and in vitro cytotoxicity study using HT-29 cells
  71. Development of a Berberine Loaded Multifunctional Design for the Treatment of Helicobacter pylori Induced Gastric Ulcer
  72. Microemulsion as drug and gene delivery vehicle: an inside story
  73. List of contributors
  74. Colorectal cancer-targeted delivery of oxaliplatin via folic acid-grafted solid lipid nanoparticles: preparation, optimization, and in vitro evaluation
  75. Recent Advances and Applications of Biosensors in Novel Technology
  76. Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization
  77. A novel sustained release drug–resin complex-based microbeads of ciprofloxacin HCl
  78. Development and in vitro characterization of a multiparticulate delivery system for acyclovir-resinate complex